In the title compound, C24H25N3O5, the benzimidazole and benzodioxole ring systems are each approximately planar [maximum deviations = 0.043 (1) and 0.036 (1) Å, respectively]. Their mean planes form a dihedral angle of 42.85 (4)°. The pyrrolidine ring has an envelope conformation with one of the methylene C atoms forming the flap. In the crystal, weak C—H⋯O hydrogen bonds link the molecules into a three-dimensional network. The crystal packing is further stabillized by weak π–π interactions between the benzene rings within the benzimidazole ring system [centroid–centroid distance = 3.7955 (7) Å]. A weak C—H⋯π interaction involving the benzodioxole ring is also present.
In the title compound, C23H24N4O5, the essentially planar benzimidazole ring system [maximum deviation = 0.008 (2) Å] forms a dihedral angle of 39.22 (7)° with the attached nitrobenzene ring. The pyrrolidin-2-one ring adopts an envelope conformation with a C atom as the flap. In the crystal, molecules are connected by C—H⋯O interactions, forming sheets propagating in (011). The crystal packing also features weak π–π stacking interactions [centroid–centroid = 3.6746 (12) Å].
The asymmetric unit of the title compound, C27H32N4O4·H2O, contains two independent benzimidazole-5-carboxylate molecules and two water molecules. In both main molecules, the pyrrolidine rings are in an envelope conformation with a methylene C atom as the flap. The morpholine rings adopt chair conformations. Both benzimidazole rings are essentially planar, with maximum deviations of 0.008 (1) Å, and form dihedral angles of 37.65 (6) and 45.44 (6)° with the benzene rings. In one molecule, an intramolecular C—H⋯O hydrogen bond forms an S(7) ring motif. In the crystal, O—H⋯O and O—H⋯N hydrogen bonds connect pairs of main molecules and pairs of water molecules into two independent centrosymmetric four-compoment aggregates. These aggregates are connect by C—H⋯O hydrogen bonds leading to the formation of a three-dimensional network, which is stabilized by C—H⋯π interactions.
In the title compound, C23H25N3O3, the benzimidazole ring system is essentially planar [maximum deviation = 0.0240 (18) Å]. The mean plane through this ring system forms a dihedral angle of 42.23 (7)° with the benzene ring. The pyrrolidine ring is in an envelope conformation with the flap atom disordered over two sites with occupancies of 0.813 (11) and 0.187 (11). In the crystal, weak C—H⋯O hydrogen bonds form R
2(10) ring motifs, which are connected by further C—H⋯O interactions, forming ribbons along the b axis. The crystal structure is further stabilized by weak π–π interactions involving the imidazole and benzene rings of the benzimidazole ring system [centroid–centroid distances = 3.6788 (11) and 3.6316 (10) Å] and weak C—H⋯π interactions.
In the title compound, C22H14N4, a new substituted benzimidazole, three intermolecular C—H⋯N interactions link neighbouring molecules into different dimers with R
2(8) and R
2(24) ring motifs. A fourth C—H⋯N interaction links neighbouring molecules along the c axis. There is also a short intermolecular contact between the azomethine (C=N) segment of the benzimidazole ring and one of the C atoms of a neighbouring benzene ring [N⋯C = 3.191 (5), C⋯C = 3.364 (6) Å], which links the molecules along the a axis. The two cyanobenzene rings are almost perpendicular to each other, with an interplanar angle of 87.70 (7)°. The dihedral angles between the mean planes of the benzimidazole ring and the two outer benzene rings are 36.27 (16) and 86.70 (16)°. In the crystal structure, molecules are stacked down the a axis with centroid–centroid distances of 3.906 (2)–3.912 (2) Å and interplanar distances of 3.5040 (17) and 3.6235 (17) Å.
In the title compound, C28H27FN4O3·H2O, the benzimidazole ring system is essentially planar with a maximum deviation of 0.028 (1) Å. It makes dihedral angles of 47.59 (5) and 60.31 (5)°, respectively, with the pyridine and benzene rings, which make a dihedral angle of 22.58 (6)° with each other. The pyrrolidine ring shows an envelope conformation with one of the methylene C atoms as the flap. In the crystal, the components are connected into a tape along the b-axis direction through O—H⋯O and O—H⋯N hydrogen bonds and a π–π interaction between the pyridine and benzene rings [centroid–centroid distance of 3.685 (8) Å]. The tapes are further linked into layers parallel to the ab plane by C—H⋯O and C—H⋯F interactions.
In the title compound, C24H27N3O5·H2O, the essentially planar benzimidazole ring system [maximum deviation = 0.020 (1) Å] forms dihedral angles of 54.10 (11) and 67.79 (6)°, respectively, with the mean plane of pyrrolidin-2-one ring and the benzene ring. The pyrrolidin-2-one ring adopts an envelope conformation with one of the methylene C atoms at the flap. An intramolecular C—H⋯π interaction is observed. In the crystal, O—H⋯O and O—H⋯N hydrogen bonds link the two components into a double-tape structure along the a axis. The crystal packing is further stabilized by weak π–π stacking [centroid–centroid distance = 3.6632 (9) Å] and C—H⋯O interactions.
The asymmetric unit of the title compound, C19H20N2O3, contains two molecules (A and B) with slightly different orientations of the ethyl groups with respect to the attached carboxylate groups. Intramolecular C—H⋯O hydrogen bonds generate S(8) ring motifs in both molecules A and B. In each molecule, the benzimidazole ring system is essentially planar, with maximum deviations of 0.023 (1) and 0.020 (1) Å, respectively, for molecules A and B. The dihedral angle between the benzimidazole ring system and the phenyl ring is 37.34 (5)° for molecule A and 42.42 (5)° for molecule B. In the crystal, O—H⋯N and C—H⋯O hydrogen bonds link the molecules into  columns with a cross-section of two-molecule by two-molecule wide, and further stabilization is provided by weak C—H⋯π and π–π interactions [centroid separations = 3.5207 (7) and 3.6314 (8) Å].
The title compound, 0.75C15H14N2O·0.25C15H14N2O, is a co-crystal of 2-methyl-6-(6-methyl-1H-benzimidazol-2-yl)phenol as the major component and 2-methyl-6-(5-methyl-1H-benzimidazol-2-yl)phenol as the minor component. The refined site-occupancy ratio is 0.746 (4)/0.254 (4). The conformations of both components are identical except for that of the methyl substituent on the benzene ring of the benzimidazole unit which is positionally disordered over two positions. The molecule is essentially planar, the dihedral angle between the benzimidazole plane and the benzene ring being 3.49 (4)°. An intramolecular O—H⋯N hydrogen bond generates an S(6) ring motif. In the crystal packing, molecules are linked through N—H⋯O hydrogen bonds into chains along . These chains are stacked approximately along the a-axis direction. The crystal packing is further stabilized by weak N—H⋯O and O⋯H⋯N hydrogen bonds, together with weak intermolecular C—H⋯π interactions. A π–π interaction with a centroid–centroid distance of 3.6241 (6) Å is also observed between the substituted phenyl ring and that of the benzimidazole system.
The title compound, C26H28N2O9·1.5H2O, the product of an acid-catalysed Wagner–Meerwein skeletal rearrangement, crystallizes as a sesquihydrate with the O atom of one of the two independent water molecules occupying a special position on a twofold axis. The organic molecule comprises a fused pentacyclic system containing two five-membered rings (cyclopentane and tetrahydrofuran) and three six-membered rings (piperidinone, tetrahydropyridine and benzene). The five-membered rings have the usual envelope conformations, and the central six-membered piperidinone and tetrahydropyridine rings adopt boat and sofa conformations, respectively. In the crystal, there are three independent O—H⋯O hydrogen bonds, which link the organic molecules and water molecules into complex two-tier layers parallel to (001). The layers are further linked into a three-dimensional framework by attractive intermolecular carbonyl–carbonyl interactions.
In the title molecule, C15H14N2O2, the substituted benzene ring forms a dihedral angle of 4.15 (1)° with the benzimidazole ring system. An intramolecular O—H⋯N hydrogen bond generates an S(6) ring motif. In the solid state, molecules are linked into chains along the  via intermolecular bifurcated N—H⋯(O,O) hydrogen bonds, which generate R
2(5) ring motifs. The crystal packing is also consolidated by C—H⋯π interactions, and π–π stacking interactions between the imidazole and substituted benzene rings [centroid–centroid distance = 3.5746 (13) Å]. The methyl group attached to the benzimidazole ring system is disordered over two positions with occupancies of 0.587 (6) and 0.413 (6), suggesting 180° rotational disorder for the benzimidazole group.
The asymmetric unit of the title compound, C22H20N2O4·H2O, comprises a substituted benzimidazole molecule and a water molecule of crystallization. The dihedral angles between the benzimidazole ring system and the two outer benzene rings are 16.54 (4) and 86.13 (4)°. The dihedral angle between the two hydroxy-substituted benzene rings is 82.20 (5)°. In the crystal structure, intermolecular O—H⋯O hydrogen bonds, involving the hydroxy groups and water molecules, form R
4(8) ring motifs, and link symmetry-related molecules into extended chains along the c axis. The crystal structure is further stabilized by weak intermolecular C—H⋯O hydrogen bonds, weak C—H⋯π and π–π stacking [centroid–centroid = 3.6495 (6)–3.7130 (6) Å] interactions. Intramolecular O—H⋯O and O—H⋯N interactions are also present.
The asymmetric unit of the title compound, C20H14N4·CH4O, contains two independent half-molecules, each located on an inversion centre, and a methanol solvent molecule. The benzimidazolyl groups form different dihedral angles [24.0 (1) and 11.6 (1)°] with the plane of the central benzene ring in the two molecules. In the crystal, a two-dimensional network is formed through N—H⋯ N, N—H⋯O and O—H⋯N hydrogen-bonding interactions between the benzimidazole units and methanol solvent molecules. π–π stacking interactions also occur between the benzimidazole rings of adjacent molecules, with centroid–centroid distances of 3.720 (14) Å and interplanar distances of 3.53 (1) Å .
In the title compound, the pyran and pyrone rings adopt slightly distorted half-chair and envelope conformations, respectively. In the crystal, C—H⋯O and π–π interactions connect the molecules, forming double layers that stack along the c-axis direction.
In the title compound, C30H28N2O6, the pyran ring adopts a slightly distorted half-chair conformation and the pyrone ring adopts an envelope conformation, with the C atom bearing the carboxylate group as the flap. The pyrazole ring [maximum deviation = 0.002 (2) Å] forms a dihedral angle of 13.2 (1)° with the attached benzene ring. The near-planar atoms of the pyran ring and the pyrazole ring are close to coplanar, the dihedral angles between their mean planes being 6.4 (1)°. The dihedral angle between the pyrone ring and the benzene ring of the chromene unit is 10.7 (1)°. The molecular conformation is stabilized by an intramolecular C—H⋯O hydrogen bond, which generates an S(6) ring motif. In the crystal, C—H⋯O interactions generate supramolecular chains propagating in  and these are connected into double layers that stack along the c-axis direction by weak π–π interactions between pyrazole rings [centroid–centroid distance = 3.801 (1) Å].
crystal structure; conformation; crystal packing; chromene
The title Schiff base compound, C15H14N2O2, consists of two crystallographically independent molecules, A and B. Molecule A is almost planar, whereas molecule B is slightly twisted, the dihedral angles between the benzimidazole group and the benzene rings being 2.65 (12) and 13.17 (15)°, respectively. The methyl group of molecule B is disordered over two positions, with a refined site-occupancy ratio of 0.581 (7):0.419 (7). In each molecule, intramolecular O—H⋯N hydrogen bonds generate S(6) ring motifs. In the crystal structure, both types of molecules are linked via intermolecular bifurcated N—H⋯O hydrogen bonds into one-dimensional extended chains along  and form R
2(5) ring motifs. The crystal structure is further stabilized by intermolecular C—H⋯π and π–π interactions [centroid–centroid distances = 3.4758 (16)–3.596 (2) Å].
In the title compound, C26H26ClN3O2·C3H7OH, the benzimidazole ring system is essentially planar [maximum deviation = −0.018 (2) Å] and its mean plane is oriented with respect to the two benzene rings at dihedral angles of 4.51 (6) and 56.16 (6)°, and the dihedral angle between the two benzene rings is 59.11 (7)°. The morpholine ring displays a chair conformation. The propan-2-ol solvent molecule links with the benzimidazole ring via an O—H⋯N hydrogen bond. In the crystal, weak intermolecular C—H⋯O hydrogen bonds link the molecules into inversion dimers with an R
2(28) motif. π–π stacking occurs between the parallel chlorobenzene rings [centroid–centroid distance = 3.792 (1) Å]. Weak C—H⋯π interactions and short Cl⋯Cl [3.2037 (10) Å] contacts are also observed.
Two crystallographically independent molecules, A and B, with similar conformations are present in the asymmetric unit of the title compound, C18H16F2N4O4. In molecule A, the plane of the 1,2,4-triazole ring is tilted relative of the 4-difluoromethoxy-substituted and the 3,4-dimethoxy-substituted benzene rings by 6.5 (2) and 16.4 (1)°, respectively. The –CHF2 group is twisted away from the plane of the benzene ring, with a dihedral angle between the O—C bond of the OCHF2 group and the plane of the adjacent phenyl ring of 38.6 (3)°. The corresponding parameters for molecule B are 7.7 (1), 9.5 (2) and 25.2 (2)°. In both molecules, the conformations are stabilized by intramolecular N—H⋯N and C—H⋯O hydrogen bonds. There are also C—H⋯π contacts between the methyl groups and the benzene rings, and π–π stacking interactions between the benzene rings of adjacent parallel A molecules [centroid–centroid distance = 3.8942 (17) Å]. π–π interactions are also observed between the triazole ring and one of the benzene rings of parallel B molecules [centroid–centroid distance = 3.7055 (16) Å].
The molecule of the title ZnII complex, [Zn(C9H10NO2)2(C6H6N2O)(H2O)2], contains two 4-(dimethylamino)benzoate (DMAB) ligands, one isonicotinamide (INA) ligand and two water molecules; one of the DMAB ions acts as a bidentate ligand while the other and INA are monodentate ligands. The four O atoms in the equatorial plane around the Zn atom form a distorted square-planar arrangement, while the distorted octahedral coordination is completed by the N atom of the INA ligand and the O atom of the water molecule in the axial positions. Intramolecular C—H⋯O hydrogen bonding results in the formation of a six-membered ring adopting an envelope conformation. The dihedral angle between the carboxyl groups and the adjacent benzene rings are 4.87 (16) and 2.2 (2)°, while the two benzene rings are oriented at a dihedral angle of 65.13 (8)°. The dihedral angle between the benzene and pyridine rings are 11.47 (7) and 74.83 (8)°, respectively. In the crystal structure, intermolecular O—H⋯O, O—H⋯N and N—H⋯O hydrogen bonds link the molecules into a supramolecular structure. π–π contacts between the pyridine and benzene rings and between the benzene rings [centroid–centroid distances = 3.695 (1) and 3.841 (1) Å, respectively] further stabilize the structure. Weak intermolecular C—H⋯π interactions are also present.
The asymmetric unit of the title compound, C11H10ClN3O, contains two geometrically different molecules, A and B, in both of which the pyridazine rings are essentially planar with r.m.s. deviations of 0.0137 and 0.0056Å, respectively. In molecule A, the dihedral angle between the pyridazine and benzene rings is 6.5 (2)°, whereas in molecule B it is 27.93 (7)°. In molecule B, an intramolecular N—H⋯O hydrogen bond forms an S(5) ring motif. In both molecules, S(6) ring motifs are present due to non-classical C—H⋯N hydrogen bonds. The π–π interactions between the pyridazine rings of A molecules [3.4740 (13) Å] and B molecules [3.4786 (17) Å] have very similar centroid–centroid separations. π–π Interactions also occur between the benzene rings of B molecules with a centroid–centroid separation of 3.676 (2) Å and a slippage of 1.02 Å. In the crystal, the molecules are linked into chains extending along  by C—H⋯N and C—H⋯Cl interactions.
The asymmetric unit of the title compound, C22H21NO, consists of two crystallographically independent molecules (A and B). Each molecule contains two benzene rings and one dimethylbenzene ring. The dihedral angle between the two benzene rings is 87.75 (16)° in molecule A and 89.25 (16)° in molecule B. In molecule A, the dimethylbenzene ring forms dihedral angles of 89.65 (8) and 42.98 (11)° with the two benzene rings, whereas the corresponding angles are equal to 63.15 (7) and 58.67 (10)° in molecule B. An intramolecular C—H⋯O hydrogen bond generates an S(6) ring motif in each molecule. In the crystal, molecules are linked by bifurcated (N,C)—H⋯O hydrogen bonds, generating R
1(6) ring motifs and forming infinite chains along the a axis. The crystal is further stabilized by C—H⋯π and π–π interactions with centroid–centroid distances of 3.8543 (18) and 3.930 (2) Å.
In the title hydrated symetrically substituted 1,3-bis(4-methylbenzyl)benzimidazolium salt, C23H23N2
+·Br−·H2O, the dihedral angles between the benzimidazole ring system (r.m.s. deviation = 0.003 Å) and the pendant benzene rings are 73.18 (16) and 77.52 (16)°. Both benzene rings lie to the same side of the benzimidazole ring system, giving the cation an overall U-shape. In the crystal, the cation is linked to the water molecule by a short C—H⋯O hydrogen bond and the water molecule forms O—H⋯Br hydrogen bonds. Together, these interactions lead to  chains. The packing is consolidated by C—H⋯Br hydrogen bonds and aromatic π–π stacking interactions [centroid–centroid distances = 3.5401 (17) and 3.8815 (18) Å], generating a three-dimensional network.
crystal structure; 1,3-bis(4-methylbenzyl)-1H-3,1-benzimidazol-3-ium bromide monohydrate; benzimidazolium salts; N-heterocyclic carbenes; hydrogen bonds; aromatic π–π stacking interactions
The title compound, C18H23N2Si+·Cl−·H2O, was synthesized from 1-[(trimethylsilyl)methyl]benzimidazole and benzyl chloride in dimethylformamide. The benzimidazole ring system is approximately planar, with a maximum deviation of 0.022 (2) Å, and makes an angle of 74.80 (12)° with the phenyl ring. The crystal packing is stabilized by O—H⋯Cl, C—H⋯Cl, C—H⋯O and C—H⋯π interactions between symmetry-related molecules together with π–π stacking interactions between the imidazolium and benzene rings [centroid–centroid distance = 3.5690 (15) Å] and between the benzene rings [centroid–centroid distance = 3.7223 (14) Å].
The title molecular salt, C13H11N2O+·Cl−·H2O, crystallizes as a monohydrate. In the cation, the phenol and benzimidazole rings are almost coplanar, making a dihedral angle of 3.18 (4)°. The chloride anion and benzimidazole cation are linked by two N+—H⋯Cl− hydrogen bonds, forming chains propagating along . These chains are linked through O—H⋯Cl hydrogen bonds involving the water molecule and the chloride anion, which form a diamond core, giving rise to the formation of two-dimensional networks lying parallel to (10-2). Two π–π interactions involving the imidazolium ring with the benzene and phenol rings [centroid–centroid distances = 3.859 (3) and 3.602 (3) Å, respectively], contribute to this second dimension. A strong O—H⋯O hydrogen bond involving the water molecule and the phenol substituent on the benzimidazole unit links the networks, forming a three-dimensional structure.
In the title compound, C13H8ClN3O3·C3H7NO, the benzimidazole and benzene rings make a dihedral angle of 0.63 (11)°. An intramolecular O—H⋯N hydrogen bond generates an S(6) ring motif. The solvent molecule is hydrogen-bonded to the benzimidazole molecule by intermolecular N—H⋯O and C—H⋯O hydrogen bonds, generating an R
2(7) ring motif. In the crystal, the molecules are arranged into parallel layers perpendicular to the c axis and stabilized by weak π–π interactions [centroid–centroid distances in the range 3.4036 (18)–3.5878 (16) Å].
In the title compound, C25H27N2
+·Br−·H2O, the benzimidazole unit is essentially planar, with a maximum deviation of 0.020 (6) Å. The benzimidazole unit makes dihedral angles of 83.6 (3) and 81.0 (3)° with the two terminal phenyl rings. The dihedral angle between the phenyl rings is 58.5 (4)°. In the crystal structure, there are C—H⋯O hydrogen bonds, a C—H⋯π interaction between a phenyl H atom and the phenyl ring of a neighbouring molecule, and a π–π interaction [3.512 (3) Å] between the centroids of the five-membered ring and the benzene ring of the benzimidazole unit of an adjacent molecule.